Hayden Amy J, Rains Melissa, Tiver Kenneth
Department of Radiation Oncology, Nepean Cancer Care Centre, Sydney, New South Wales, Australia.
J Med Imaging Radiat Oncol. 2012 Aug;56(4):464-72. doi: 10.1111/j.1754-9485.2012.02405.x.
Adjuvant left breast radiotherapy (ALBR) for breast cancer can result in significant radiation dose to the heart. Current evidence suggests a dose-response relationship between the risk of cardiac morbidity and radiation dose to cardiac volumes. This study explores the potential benefit of utilising a deep inspiration breath hold (DIBH) technique to reduce cardiac doses.
Thirty patients with left-sided breast cancer underwent CT-simulation scans in free breathing (FB) and DIBH. Treatment plans were generated using a hybrid intensity-modulated radiation therapy technique with simultaneous integrated boost. A dosimetric comparison was made between the two techniques for the heart, left anterior descending coronary artery (LAD), left lung and contralateral breast.
Compared with FB, DIBH resulted in a significant reduction in heart V30 (7.1 vs. 2.4%, P < 0.0001), mean heart dose (6.9 vs. 3.9 Gy, P < 0.001), maximum LAD planning risk volume (PRV) dose, (51.6 vs. 45.6 Gy, P = 0.0032) and the mean LAD PRV dose (31.7 vs. 21.9 Gy, P < 0.001). No significant difference was noted for lung V20, mean lung dose or mean dose to the contralateral breast. The DIBH plans demonstrated significantly larger total lung volumes (1126 vs. 2051 cc, P < 0.0001), smaller maximum heart depth (2.08 vs. 1.17 cm, P < 0.0001) and irradiated heart volume (36.9 vs. 12.1 cc, P < 0.0001).
DIBH resulted in a significant reduction in radiation dose to the heart and LAD compared with an FB technique for ALBR. Ongoing research is required to determine optimal cardiac dose constraints and methods of predicting which patients will derive the most benefit from a DIBH technique.
乳腺癌的辅助性左乳放疗(ALBR)可导致心脏接受显著的辐射剂量。目前的证据表明,心脏发病率风险与心脏体积的辐射剂量之间存在剂量反应关系。本研究探讨了采用深吸气屏气(DIBH)技术降低心脏剂量的潜在益处。
30例左侧乳腺癌患者在自由呼吸(FB)和DIBH状态下接受CT模拟扫描。使用混合调强放射治疗技术并同步整合加量来生成治疗计划。对心脏、左前降支冠状动脉(LAD)、左肺和对侧乳房在两种技术下进行剂量学比较。
与FB相比,DIBH使心脏V30显著降低(7.1%对2.4%,P<0.0001),平均心脏剂量显著降低(6.9 Gy对3.9 Gy,P<0.001),LAD最大计划靶体积(PRV)剂量显著降低(51.6 Gy对45.6 Gy,P = 0.0032),LAD平均PRV剂量显著降低(31.7 Gy对21.9 Gy,P<0.001)。肺V20、平均肺剂量或对侧乳房平均剂量未观察到显著差异。DIBH计划显示总肺体积显著更大(1126 cc对2051 cc,P<0.0001),最大心脏深度显著更小(2.08 cm对1.17 cm,P<0.0001),受照射心脏体积显著更小(36.9 cc对12.1 cc,P<0.0001)。
与用于ALBR的FB技术相比,DIBH使心脏和LAD的辐射剂量显著降低。需要持续研究以确定最佳心脏剂量限制以及预测哪些患者将从DIBH技术中获益最多的方法。